Transcat, Inc. (TRNS) has a MoatMap StockRank of 68/100 based on Quality (53/100), Value (24/100), and Momentum (75/100) factor scores. The current signal is BUY. Transcat is a high-quality calibration services provider, but it lacks a strong macro tailwind from our identified themes over the next 18 months. While it is a steady compounder, it does not offer the asymmetric macro-driven upside we seek.
Transcat is a leading provider of accredited calibration, repair, and specialty measurement services, as well as a distributor of professional grade handheld test instruments. The company primarily serves highly regulated industries, such as life sciences, aerospace, and defense, where precise measurement is legally mandated. Its competitive moat is sustained by a vast network of accredited labs, proprietary asset management software, and exceptionally high customer switching costs.
| Price | $90.00 |
| Market Cap | $738M |
| P/E (TTM) | 163.58 |
| P/E (Forward) | 43.52 |
| Price/Book | 2.93 |
| Return on Equity | 1.8% |
| Return on Invested Capital | 5.4% |
| Debt/Equity | 44.33 |
| Gross Margin | 32.6% |
| Operating Margin | 6.1% |
| Revenue Growth | 15.8% |
| Free Cash Flow | $21M |
Transcat, Inc. operates in the Specialty Business Services industry, part of the Industrials sector (United States).